絞り込み

16261

広告

「abatacept」の検索結果

2990件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Unsuccessful Treatment with Abatacept in Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation.

Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.

Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model.

Th17 and CD24(hi)CD27(+) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis.

Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

Maintenance Treatment using Abatacept with Dose Reduction after Achievement of Low Disease Activity in Patients with Rheumatoid Arthritis (MATADOR) - A prospective, multicenter, single arm pilot clinical trial.

Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.

Enhanced Bruton's tyrosine kinase activity in peripheral blood B lymphocytes of autoimmune disease patients.

A randomized, double-blind trial of abatacept (CTLA4-ig) for the treatment of takayasu's arteritis.

A randomized, double-blind trial of abatacept (CTLA4-IG) for the treatment of giant cell arteritis.

Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-A longitudinal analysis.

Mechanisms and New Strategies for Primary Sjögren's Syndrome.

Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression.

Detailed Analysis of the Articular Domain in Patients with Primary Sjögren Syndrome.

A comparison of discontinuation rates of tofacitinib and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis.

[Recent advances in the treatment of large vessel vasculitides].

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry.

New strategies for the treatment of IgG4-related disease.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります